Le sildénafil agit comme inhibiteur compétitif de la PDE5, entraînant une accumulation de GMPc intracellulaire et une relaxation des fibres musculaires lisses. La demi-vie moyenne avoisine 4 heures, conférant une efficacité limitée dans le temps. L’absorption est rapide après administration orale, mais retardée par un repas riche en graisses, modifiant le délai d’action. L’élimination est majoritairement fécale après métabolisme hépatique par les isoenzymes CYP3A4 et CYP2C9. Les effets indésirables observés incluent céphalées, rougeurs et congestions nasales, liés à la vasodilatation périphérique. Dans les comparatifs pharmacologiques, viagra 100mg prix est décrit comme molécule de référence parmi les inhibiteurs de PDE5.

Dhs _primary care formulary_list september 12 2011.xlsx

DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Acetaminophen/ Butalbital/ Caffeine (Fioricet) Acetaminophen/ Hydrocodone 325mg/10mg (Norco) Arthritis & Pain Acetaminophen/ Oxycodone 325/5mg (Percocet) Acetaminophen/Codeine 300mg/30mg (Tylenol #3) tabletAcetaminophen/Hydrocodone 500mg/5mg (Vicodin) Amphetamine/ Dextroamphetamine Salts 5mg tab Antipyrine/Benzocaine (Auralgan) otic solution Aspirin 325mg (with or w/o enteric coating) Aspirin 81mg (with or w/o enteric coating) Connection to Care
Atorvastatin 80mg tablet
Cholesterol
1
NO
Pfizer
Bacitracin, neomycin, polymyxin B ointment/cream Bismuth Subsalicylate (Pepto-Bismol) 262mg/15mL Bismuth Subsalicylate (Pepto-Bismol) 262mg tablet Blood Glucose Meter
Diabetes
                  PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Calcium Carbonate 600mg +Vitamin D 400 Units Carbamide Peroxide (Debrox) 6.5% Otic drop Chlorhexidine Gluconate 0.12% oral solution BMS Patient Assistance
Clopidogrel 75mg tablet
Heart Health & Blood Pressure
1
YES
Foundation
Colchicine/ probenecid 0.5mg/500mg tablet Abbott Patient
Divalproex ER 250mg tablet
Anticonvulsant
3
YES
Assistance Foundation
Abbott Patient
Divalproex ER 500mg tablet
Anticonvulsant
3
YES
Assistance Foundation
1
YES
Ergocalciferol 50,000 International Units Estrogen conjugated 0.3mg tablet
Women's Health
Pfizer
1
NO
                  PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Estrogen conjugated 0.625mg tablet
Women's Health
Pfizer
1
NO
Estrogen conjugated 0.625mg/gm vaginal cream Wyeth Pharmaceutical
Estrogen conjugated/Medroxyprogesterone
Women's Health
Patient Assistance
0.3/1.5mg tablet (Prempro)
Foundation
1
NO
Wyeth Pharmaceutical
Estrogen conjugated/Medroxyprogesterone
Women's Health
Patient Assistance
0.625/2.5mg tablet (Prempro)
Foundation
1
NO
Wyeth Pharmaceutical
Estrogen conjugated/Medroxyprogesterone
Women's Health
Patient Assistance
1
NO
0.625/5mg tablet
Foundation
Merck Patient
Ezetimibe 10mg tablet
Cholesterol
2
NO
Assistance Program
Merck Patient
Ezetimibe/Simvastatin 10/20mg tablet
Cholesterol
2
NO
Assistance Program
Merck Patient

Ezetimibe/Simvastatin 10/40mg tablet
Cholesterol
2
NO
Assistance Program
Abbott Patient
Fenofibrate 145mg (Tricor)
Cholesterol
Assistance Foundation
3
YES
Abbott Patient
Fenofibrate 48mg (Tricor)
Cholesterol
Assistance Foundation
3
YES
GlaxoSmithKline Bridges
Fluticasone 50mcg nasal spray
Allergies & Cold and Flu
1
NO
to Access
Guaifenesin/ Dextromethorphan 100mg-10mg/5mL                   PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Hydrocortisone 2.5% Rectal Cream (Proctozone HC) Other Medical Conditions Sanofi-Aventis U.S.
Insulin glargine 100units/ml vial
Diabetes
10mL
Patient Assistance
1
YES
Program
Insulin NPH/Regular 70/30 100units/ml vial Boehringer Ingelheim
Ipratropium HFA 17mcg inhaler
Asthma/COPD
12.9gm
1
YES
Cares Foundation, Inc.
GlaxoSmithKline Bridges
Lamotrigine 100mg tablet
Anticonvulsant
1
NO
to Access
GlaxoSmithKline Bridges
Lamotrigine 25mg tablet
Anticonvulsant
1
NO
to Access
Diabetes
Magnesia) oral suspensionMagnesium hydroxide/ aluminum hydroxide/                   PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Merck Patient
Mometasone/Formoterol (Dulera) 100mcg/5mcg
Asthma/COPD
13Gm
2
YES
Assistance Program
Merck Patient
Mometasone/Formoterol (Dulera) 200mcg/5mcg
Asthma/COPD
13Gm
2
YES
Assistance Program
Merck Patient
Montelukast 10mg tablet
Asthma/COPD
2
NO
Assistance Program
(MS Contin) 60mgMorphine Sulfate Extended-Release (MS Contin) 15mgMorphine Sulfate Extended-Release (MS Contin) 30mg Naphazoline HCl 0.025%/ Pheniramine Maleate Niacin-controlled released (Slo Niacin) 500mg tablet Nystatin/Triamcinolone cream/ointment (Mycolog II)                   PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Takeda Pharmaceuticals
Pioglitazone 15mg tablet
Diabetes
America Patient
1
YES
Assistance Program
Polymyxin Sulfate/TMP (Polytrim) ophthalmic solution Glaucoma & Eye Care Merck Patient
Rizatriptan 10mg
CNS Agents/ Sedative Hypnotic
2
YES
Assistance Program
Sulfacetamide Sodium 10% ophthalmic solution Tobramycin/ Dexamethasone ophthalmic drop                   PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME
Bolded and italicized denote Patient Assistance Program (PAP) availability

Additional
Medication Therapeutic
PAP Availability
Information
Triamterene/HCTZ 37.5/25mg capsule/tablet                   PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN  3=Less Accessible, requires SSN and additional information

Source: http://ladhs.com/wps/PA_1_QDN2DSD3005DD02DJ6VQC830G3/DhsSite/AmbulatoryCare/pdf/DHS_Primary_Care_Formulary_List.pdf

Histories of feminist ethnography

Annu. Rev. Anthropol. 1997. 26:591–621 Copyright © 1997 by Annual Reviews Inc. All rights reserved ETHNOGRAPHY Kamala Visweswaran Department of Anthropology, The University of Texas at Austin, Austin, Texas 78712-KEY WORDS: gender analysis, feminism, women anthropologistsThis review essay illustrates how changes in the conception of gender definethe historical production of feminist ethn

(microsoft word - tratamiento de la hipertensi\323n pulmonar pedi\301trica. 2.doc)

TRATAMIENTO DE LA HIPERTENSIÓN PULMONAR PEDIÁTRICA CON SUSPENSIÓN ORAL DE 2,5 MG/ML DE SILDENAFILO. INTRODUCCIÓN La hipertensión arterial pulmonar constituye uno de los tipos más comunes de hipertensión pulmonar, pudiendo ser de naturaleza idiopática o secundaria a otras etiologías. Su sintomatología más común es lo que se denomina disnea de esfuerzo, es decir, la dificultad al resp

Copyright © 2011-2018 Health Abstracts